Summary of Stock Options Outstanding under Plans |
The table below provides stock option information for the six months ended June 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted- Average Exercise Price Per Share |
|
Weighted- Average Remaining Contractual Life |
|
Aggregate Intrinsic Value of In-the- Money Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
364,088 |
|
|
$ |
17.86 |
|
|
5.9 years |
|
$ |
4,548 |
|
(1) |
Options exercised |
(25,750 |
) |
|
$ |
22.06 |
|
|
5.9 years |
|
— |
|
|
Options outstanding at end of period |
338,338 |
|
|
$ |
17.54 |
|
|
5.5 years |
|
$ |
3,657 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
338,338 |
|
|
$ |
17.54 |
|
|
5.5 years |
|
$ |
3,657 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $30.35 as of December 31, 2017, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $28.35 as of June 30, 2018, over the exercise price, multiplied by the number of options.
|
The table below provides stock option information for the three months ended June 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted- Average Exercise Price Per Share |
|
Weighted- Average Remaining Contractual Life |
|
Aggregate Intrinsic Value of In-the- Money Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
338,338 |
|
|
$ |
17.54 |
|
|
5.5 years |
|
$ |
4,469 |
|
(1) |
|
|
|
|
|
|
|
|
|
Options outstanding at end of period |
338,338 |
|
|
$ |
17.54 |
|
|
5.5 years |
|
$ |
3,657 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
338,338 |
|
|
$ |
17.54 |
|
|
5.5 years |
|
$ |
3,657 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $30.75 as of March 31, 2018, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $28.35 as of June 30, 2018, over the exercise price, multiplied by the number of options.
|
|
Schedule of Restricted Stock Awards |
The table below provides information for restricted stock awards for the three and six months ended June 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2018 |
|
Six Months Ended June 30, 2018 |
|
Number of Shares |
|
Weighted- Average Grant Date Fair Value Per Share |
|
Number of
Shares
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share
|
Restricted stock at beginning of period |
324,096 |
|
|
$ |
22.38 |
|
|
317,783 |
|
|
$ |
21.09 |
|
Restricted stock granted |
21,670 |
|
|
29.10 |
|
|
119,394 |
|
|
24.99 |
|
Restricted stock vested |
(25,741 |
) |
|
25.87 |
|
|
(78,654 |
) |
|
26.54 |
|
Restricted stock forfeited |
(4,520 |
) |
|
29.89 |
|
|
(43,018 |
) |
|
12.06 |
|
Restricted stock at end of period |
315,505 |
|
|
22.44 |
|
|
315,505 |
|
|
22.44 |
|
|